Page results
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
NBA Legend Isiah Thomas visited young basketball fans in the University College Hospital Macmillan Cancer Centre to chat with patients and staff, sign autographs and take selfies.
-
Read more about a UCLH patient saved by special 'before midnight' transfusions.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
UCLH will play a vital role in a new respiratory virus study.
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
File results
-
FOI/2024/0561 - Gender reassignment and/or transgender policies, mixed/same sex accommodation and Equality Impact Assessments (EIA)
-
FOI/2024/0560 - Coroners' Prevention of Future Deaths Reports
-
FOI/2024/0559 - Surgical Robots purchase/ simulators/ procedures 2019-2024
-
FOI/2024/0455 - Information Governance structure
-
FOI/2024/0541 - Healthcare-associated infections (HAIs) 2022-2024
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0534 - NHS staff absence rates
-
FOI/2024/0542 - Single-use medical items usage at Trust
-
FOI/2024/0450 - Trust-wide obesity and weight management strategy
-
FOI/2024/0440 - Patient reported outcome measures (PROMs) in oncology